Oral Estriol

Synthetic Biologics Reports 2011 Year End Financial ResultsThe pharmaceutical startup Synthetic Biologics Inc. (NYSE Amex: SYN) reported a larger loss for the year ended Dec. 31, but also a host of promising operational highlights.
Adeona Starts Phase II Trials Of New MS DrugAdeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had started a Phase II clinical trial of Trimesta (oral estriol) for the treatment of cognitive dysfunction in multiple sclerosis in women.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen